Endocrine Abstracts

Introduction: Being overweight or obese are common characteristic of women affected by polycystic ovary syndrome (PCOS). Indeed, 50–70% of the women are obese and more likely to present with higher growth rate and obesity already from early childhood compared with women without the syndrome. Obesity predisposes women with PCOS to adverse metabolic outcomes such as metabolic syndrome, insulin resistance and diabetes. Recent studies have also revealed a high prevalence of e...

Background: Women with polycystic ovary syndrome (PCOS) experience increased weight gain during life, thus weight management and preventing weight gain should be the first line treatment. Weight loss is usually self-initiated because practical support for weight management is often limited or even lacking. Perception of overweight is considered an important prerequisite for weight loss attempts, although there is no prior research regarding women with PCOS. The main aim of the...

It has been reported that women with polycystic ovary syndrome (PCOS) show cardiovascular autonomic dysfunction, with reduced parasympathetic (vagal) and increased sympathetic activity, which are known to be independent risk factors for cardiovascular morbidity and mortality. However, it is not yet clear if PCOS per se leads to cardiovascular autonomic dysfunction independently of metabolic abnormalities. In a prospective, general population-based follow-up birth coho...